 Laura Fenton
Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Stem Neoplasms | 5 | 2015 | 84 | 0.830 |
Why?
| | Magnetic Resonance Imaging | 19 | 2024 | 3039 | 0.780 |
Why?
| | Tomography, X-Ray Computed | 9 | 2014 | 2272 | 0.750 |
Why?
| | Neuroimaging | 1 | 2022 | 249 | 0.700 |
Why?
| | Brain | 6 | 2022 | 2355 | 0.650 |
Why?
| | Ganglioglioma | 2 | 2015 | 29 | 0.580 |
Why?
| | Esophagus | 3 | 2015 | 224 | 0.570 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 249 | 0.570 |
Why?
| | Scrotum | 1 | 2016 | 23 | 0.520 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 11 | 0.510 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 295 | 0.510 |
Why?
| | Brain Diseases | 2 | 2019 | 124 | 0.500 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 45 | 0.490 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 44 | 0.440 |
Why?
| | Child | 33 | 2024 | 18400 | 0.440 |
Why?
| | Ultrasonography | 3 | 2016 | 635 | 0.440 |
Why?
| | Eosinophils | 1 | 2015 | 276 | 0.440 |
Why?
| | Glioma | 2 | 2009 | 285 | 0.430 |
Why?
| | Osteitis | 1 | 2013 | 3 | 0.430 |
Why?
| | Child, Preschool | 23 | 2019 | 9114 | 0.420 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 260 | 0.420 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 191 | 0.400 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 70 | 0.400 |
Why?
| | Gastritis | 1 | 2013 | 84 | 0.390 |
Why?
| | Enteritis | 1 | 2013 | 82 | 0.390 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 22 | 0.380 |
Why?
| | Radiography | 8 | 2016 | 803 | 0.360 |
Why?
| | Eosinophilia | 1 | 2013 | 186 | 0.360 |
Why?
| | Infant | 20 | 2019 | 7943 | 0.360 |
Why?
| | Colitis | 1 | 2013 | 223 | 0.350 |
Why?
| | Spinal Fusion | 1 | 2013 | 199 | 0.350 |
Why?
| | Radiation Injuries | 2 | 2019 | 128 | 0.350 |
Why?
| | Nervous System Diseases | 1 | 2011 | 254 | 0.310 |
Why?
| | Male | 39 | 2019 | 55396 | 0.300 |
Why?
| | Adolescent | 24 | 2019 | 17800 | 0.290 |
Why?
| | Female | 44 | 2019 | 59325 | 0.290 |
Why?
| | Pamphlets | 1 | 2007 | 22 | 0.280 |
Why?
| | Mutation | 3 | 2014 | 3338 | 0.280 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1690 | 0.280 |
Why?
| | Astrocytoma | 2 | 2007 | 106 | 0.280 |
Why?
| | Infant, Newborn | 16 | 2019 | 5038 | 0.280 |
Why?
| | Humans | 56 | 2024 | 114043 | 0.270 |
Why?
| | Deglutition Disorders | 2 | 2020 | 117 | 0.270 |
Why?
| | Brain Neoplasms | 3 | 2012 | 966 | 0.270 |
Why?
| | Reproducibility of Results | 6 | 2015 | 2764 | 0.270 |
Why?
| | Radiation Dosage | 1 | 2007 | 133 | 0.260 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 210 | 0.260 |
Why?
| | Liver Neoplasms | 2 | 2008 | 504 | 0.260 |
Why?
| | Stroke | 3 | 2022 | 1019 | 0.260 |
Why?
| | Diagnosis, Differential | 7 | 2013 | 1331 | 0.260 |
Why?
| | Retrospective Studies | 14 | 2024 | 12521 | 0.250 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 18 | 0.240 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 6 | 0.230 |
Why?
| | Venous Thrombosis | 2 | 2016 | 141 | 0.220 |
Why?
| | Scurvy | 1 | 2024 | 12 | 0.220 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 58 | 0.210 |
Why?
| | Cerebral Cortex | 2 | 2019 | 380 | 0.210 |
Why?
| | Neuroblastoma | 2 | 2010 | 133 | 0.210 |
Why?
| | Encephalocele | 1 | 2022 | 6 | 0.210 |
Why?
| | Brain Stem | 1 | 2003 | 94 | 0.200 |
Why?
| | Teratoma | 1 | 2003 | 92 | 0.200 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 80 | 0.200 |
Why?
| | Diagnostic Errors | 1 | 2003 | 150 | 0.200 |
Why?
| | Child Abuse | 2 | 2012 | 456 | 0.190 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 90 | 0.180 |
Why?
| | Parietal Bone | 1 | 2000 | 11 | 0.180 |
Why?
| | Connective Tissue | 1 | 2000 | 36 | 0.180 |
Why?
| | Skull Fractures | 1 | 2000 | 28 | 0.180 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 18 | 0.180 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.170 |
Why?
| | Prognosis | 5 | 2014 | 3315 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 76 | 0.170 |
Why?
| | Radiotherapy | 2 | 2019 | 175 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 39 | 0.170 |
Why?
| | Parents | 1 | 2007 | 1181 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1168 | 0.160 |
Why?
| | Intestine, Small | 1 | 2000 | 121 | 0.160 |
Why?
| | Bevacizumab | 1 | 2019 | 114 | 0.160 |
Why?
| | Corpus Callosum | 1 | 2019 | 56 | 0.160 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1356 | 0.160 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 42 | 0.160 |
Why?
| | Esophagoscopy | 2 | 2020 | 181 | 0.150 |
Why?
| | tau Proteins | 1 | 2019 | 66 | 0.150 |
Why?
| | Fatty Liver | 2 | 2012 | 209 | 0.150 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 115 | 0.150 |
Why?
| | Disease-Free Survival | 2 | 2014 | 618 | 0.150 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 158 | 0.150 |
Why?
| | Young Adult | 6 | 2015 | 10444 | 0.150 |
Why?
| | Treatment Outcome | 8 | 2014 | 9049 | 0.150 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 221 | 0.150 |
Why?
| | Fatal Outcome | 4 | 2016 | 281 | 0.150 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 125 | 0.150 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 213 | 0.140 |
Why?
| | White Matter | 1 | 2019 | 105 | 0.140 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.140 |
Why?
| | Moyamoya Disease | 1 | 2017 | 14 | 0.140 |
Why?
| | Multimodal Imaging | 2 | 2019 | 89 | 0.140 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.140 |
Why?
| | Hyperammonemia | 1 | 2016 | 15 | 0.140 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 7 | 0.140 |
Why?
| | Leigh Disease | 2 | 2013 | 17 | 0.130 |
Why?
| | Stomach | 1 | 1996 | 102 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 17 | 0.130 |
Why?
| | Contrast Media | 3 | 2019 | 347 | 0.130 |
Why?
| | Brain Infarction | 1 | 2016 | 22 | 0.130 |
Why?
| | Portal Vein | 1 | 2016 | 75 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 48 | 0.130 |
Why?
| | Cerebral Veins | 1 | 2016 | 15 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 150 | 0.130 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 17 | 0.130 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 81 | 0.130 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.130 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 373 | 0.130 |
Why?
| | Cerebral Infarction | 1 | 2015 | 39 | 0.120 |
Why?
| | Temporal Lobe | 1 | 2015 | 78 | 0.120 |
Why?
| | Abdominal Pain | 2 | 2011 | 134 | 0.120 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 79 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.120 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.120 |
Why?
| | Carotid Stenosis | 1 | 2015 | 79 | 0.120 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2019 | 442 | 0.110 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 42 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| | Athletic Injuries | 2 | 2016 | 456 | 0.100 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 83 | 0.100 |
Why?
| | Pons | 1 | 2012 | 30 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 182 | 0.100 |
Why?
| | Accidents | 1 | 2012 | 39 | 0.100 |
Why?
| | Necrosis | 3 | 2019 | 209 | 0.090 |
Why?
| | Splenomegaly | 1 | 2011 | 16 | 0.090 |
Why?
| | Craniotomy | 1 | 2012 | 68 | 0.090 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 14 | 0.090 |
Why?
| | Anticoagulants | 1 | 2015 | 547 | 0.090 |
Why?
| | Decompression, Surgical | 1 | 2012 | 92 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 154 | 0.090 |
Why?
| | Liver Diseases | 2 | 2010 | 254 | 0.090 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 474 | 0.090 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.090 |
Why?
| | Scoliosis | 1 | 2013 | 178 | 0.090 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 231 | 0.090 |
Why?
| | Recurrence | 3 | 2022 | 925 | 0.090 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 66 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 76 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 70 | 0.080 |
Why?
| | Liver | 2 | 2016 | 1633 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 61 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.080 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1611 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 130 | 0.080 |
Why?
| | Facial Injuries | 1 | 2009 | 16 | 0.080 |
Why?
| | Facial Bones | 1 | 2009 | 29 | 0.080 |
Why?
| | Autopsy | 2 | 2016 | 83 | 0.080 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 281 | 0.080 |
Why?
| | Medulloblastoma | 1 | 2010 | 172 | 0.080 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 13 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 163 | 0.080 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 72 | 0.080 |
Why?
| | Obesity | 2 | 2012 | 2505 | 0.080 |
Why?
| | Lung Diseases | 1 | 2014 | 690 | 0.080 |
Why?
| | Biopsy | 2 | 2010 | 1024 | 0.080 |
Why?
| | Craniopharyngioma | 1 | 2009 | 65 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 61 | 0.080 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 51 | 0.070 |
Why?
| | Glioblastoma | 1 | 2010 | 250 | 0.070 |
Why?
| | Adult | 8 | 2019 | 30375 | 0.070 |
Why?
| | Meningomyelocele | 1 | 2008 | 54 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 84 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 104 | 0.070 |
Why?
| | Brain Injuries | 1 | 2012 | 459 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 343 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 176 | 0.070 |
Why?
| | Brain Ischemia | 1 | 2009 | 297 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 233 | 0.060 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Mucormycosis | 1 | 2005 | 20 | 0.060 |
Why?
| | Osteoporosis | 1 | 2008 | 224 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2008 | 236 | 0.060 |
Why?
| | Bone Density | 1 | 2008 | 432 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2019 | 735 | 0.060 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 320 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2016 | 4392 | 0.060 |
Why?
| | Risk Factors | 5 | 2012 | 8614 | 0.060 |
Why?
| | Sinusitis | 1 | 2005 | 174 | 0.050 |
Why?
| | Vincristine | 1 | 2003 | 98 | 0.050 |
Why?
| | Carboplatin | 1 | 2003 | 135 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 110 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 721 | 0.050 |
Why?
| | Pilot Projects | 2 | 2019 | 1360 | 0.050 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 31 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 695 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4090 | 0.050 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 12 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 237 | 0.050 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 4402 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 36 | 0.050 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 9 | 0.050 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 29 | 0.050 |
Why?
| | Mental Disorders | 1 | 2008 | 889 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 58 | 0.040 |
Why?
| | Herpes Simplex | 1 | 2000 | 87 | 0.040 |
Why?
| | Enema | 1 | 2000 | 37 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 3397 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2000 | 174 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 152 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 57 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2464 | 0.040 |
Why?
| | Neck | 1 | 2019 | 85 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 27 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 5499 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1791 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 4883 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 83 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 70 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 110 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 152 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 434 | 0.040 |
Why?
| | Phenotype | 2 | 2019 | 2784 | 0.040 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.040 |
Why?
| | Dexamethasone | 1 | 2019 | 316 | 0.040 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 15 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2017 | 108 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 33 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 27 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 511 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 72 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 127 | 0.030 |
Why?
| | Florida | 1 | 2015 | 73 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 68 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 526 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 259 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 298 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1117 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 600 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 308 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 278 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6077 | 0.030 |
Why?
| | Pedigree | 1 | 2013 | 460 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 26605 | 0.030 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 3 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2384 | 0.020 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 4 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3003 | 0.020 |
Why?
| | Aged | 2 | 2019 | 18969 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 151 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 51 | 0.020 |
Why?
| | Disabled Children | 1 | 2012 | 69 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 169 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 143 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 100 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 52 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3254 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 919 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 180 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 88 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 65 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 590 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 146 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 13 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 55 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 761 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 742 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 307 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 169 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 167 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 113 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 444 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 458 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 60 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 573 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6306 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 224 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 250 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 362 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 228 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 330 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 184 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2114 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1638 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 1981 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 14 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 15 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 467 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1624 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2783 | 0.020 |
Why?
| | Orbit | 1 | 2005 | 52 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1142 | 0.020 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 66 | 0.020 |
Why?
| | Prospective Studies | 2 | 2009 | 6195 | 0.010 |
Why?
| | United States | 1 | 2019 | 12137 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2314 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 31 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 49 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1531 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 17 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 24 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 149 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 2958 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 182 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 1957 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 190 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 332 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 93 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 1827 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 167 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 112 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 907 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 850 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 10 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 82 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 104 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 3 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 15 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 12 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 59 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 109 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 63 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 96 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 485 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 372 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 1815 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 30 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 80 | 0.000 |
Why?
| | Blood | 1 | 1975 | 94 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 81 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 144 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 96 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 155 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1089 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|